Azalanstat
Appearance
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H24ClN3O2S |
Molar mass | 429.963 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) |
Azalanstat (INN,[1] codenamed RS-21607) is an anti-obesity drug acting as a lanosterol 14α-demethylase inhibitor.[2][3]
References
- ^ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 36" (PDF). World Health Organization. p. 141. Retrieved 3 January 2017.
- ^ Walker, KA; Kertesz, DJ; Rotstein, DM; Swinney, DC; Berry, PW; So, OY; Webb, AS; Watson, DM; Mak, AY; Burton, PM (23 July 1993). "Selective Inhibition of Mammalian Lanosterol 14α-Demethylase: A Possible Strategy for Cholesterol Lowering". Journal of Medicinal Chemistry. 36 (15): 2235–7. doi:10.1021/jm00067a022. PMID 8340925.
- ^ Burton, PM; Swinney, DC; Heller, R; Dunlap, B; Chiou, M; Malonzo, E; Haller, J; Walker, KA; Salari, A; Murakami, S (8 August 1995). "Azalanstat (RS-21607), a Lanosterol 14α-Demethylase Inhibitor with Cholesterol-Lowering Activity". Biochemical Pharmacology. 50 (4): 529–44. doi:10.1016/0006-2952(95)00152-p. PMID 7646560.